Piqur Therapeutics' Seed - II Round

Piqur Therapeutics raised a round of funding on September 05, 2013.

PIQUR is a Swiss pharmaceutical company focusing on the discovery and development of anti-cancer drugs based on lipid kinase (PI3K) and mTOR inhibition. PIQUR's pipeline originates from one of the mos…

Articles about Piqur Therapeutics' Seed - II Round: